CN Stock MarketDetailed Quotes

300558 Betta Pharmaceuticals

Watchlist

55.35
+2.66+5.05%

Market Closed Nov 29 15:00 CST

23.16BMarket Cap50.41P/E (TTM)

Betta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Betta Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 818.440M	--
--	2023/Q1	-- / 531.619M	--
--	2024/Q3	843.877M / 765.760M	--
--	2024/Q2	764.990M / 770.395M	--
--	2024/Q1	735.775M / 700.292M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 818.440M--

--2023/Q1-- / 531.619M--

--2024/Q3843.877M / 765.760M--

--2024/Q2764.990M / 770.395M--

--2024/Q1735.775M / 700.292M--

Unlock Free Earnings Estimates

Open Account

Betta Pharmaceuticals Earnings Reports

Betta Pharmaceuticals: Report for the third quarter of 2024

Oct 28 12:00 ET

Betta Pharmaceuticals: Summary of Half-Year Report in 2024.

Aug 5 12:00 ET

Betta Pharmaceuticals: Half-year report for the year 2024.

Aug 5 12:00 ET

Betta Pharmaceuticals: 2024 Interim Performance Forecast

Jul 23 12:00 ET

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

Strong Buy
75.00%
Buy
25.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall